Chromosome microarray analysis (CMA), also known as "Molecular Karyotyping", is capable of scanning at genome-wide level to detect chromosomal unbalance ectopic, especially in the detection of chromosomal microdeletion and microduplication has prominent advantages.

    In Europe and  American countries, CMA has now become a conventional diagnostic tool for clinical genetics.

    In recent years, the clinical application of CMA in China has been gradually promoted, providing accurate molecular diagnosis for many people with genetic diseases. For this reason, our country has issued Expert Consensus on the Application of Chromosome Microarray Technology in Prenatal Diagnosis, Expert Consultation on Clinical Application of Chromosomal Genomic Microarray in Pediatric Genetic Diseases, in order to better exert the effect of CMA in clinical testing.

Product introduction

    Yinfeng Gene Technology Co., Ltd. has introduced Affymetrix Dx2, the most reliable testing platform of clinical medicine. Genome-wide detection for abortion tissue, amniotic fluid, fetal villous tissue, umbilical cord blood, placental tissue, peripheral blood. The reason of chromosome aneuploidy,over 100Kb of microdeletion, over 200Kb of micduplication,LOH,UPD.A comprehensive examination of miscarriage,fetal abnormalities, abnormal phenotype of newborns or children,infertility,autism,epilepsy and other reasons.

Platform introduction

    Genome-wide coverage of the probe, and clinically relevant gene areas are particularly encrypted.

    The chip covers both CNV probe and SNP probe.

    It can accurately detect chromosomal microdeletion/duplication, and the size can be accurately measured.

    It can detect loss of heterozygosity(LOH),Uniparental Disomy(UPD).

Intended for

    Prenatal diagnosis.

    Spontaneous abortion, recurrent miscarriage, abnormal fetus, stillbirth, primary infertility.

    Primary mental retardation, growth retardation, multiple congenital malformation, children with suspected chromosome disease, autism, epilepsy and so on.

    Primary mental retardation, growth retardation, developmental delay, multiple congenital malformation, children with suspected chromosome disease, autism, epilepsy and so on.